Kozma
Passo Fundo, Rio Grande do Sul, 990010-080, Brazil
NCT Number: NCT01065649
Patients with nonerosive reflux disease (NERD) are less responsive to standard treatment with proton pump inhibitors. The hypothesis of this study was that nortriptyline in analgesic doses may decrease heartburn perception and its corresponding cortical activity measured by magnetic resonance image. Therefore, the aim of this study was to assess the cortical representation of heartburn in patients with NERD under treatment with nortriptyline and placebo.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Passo Fundo, Rio Grande do Sul, 990010-080, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
It will be administered per oral 10 mg a day in the first 7 days and then 25 mg a day in the last 14 days
Placebo per oral for 21 days, equal to nortriptyline
Time frame: 3 months
Time frame: 3 months
Universidade de Passo Fundo
Other
Effect of Nortriptyline in the Cortical Representation of Heartburn in Patients With Nonerosive Reflux Disease
Acronym: NORGERD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01869491
Deglutition Disorders, Digestive System Diseases
Beijing, China
View Trial DetailsNCT01733810
Deglutition Disorders, Digestive System Diseases
Dallas, Texas, United States
View Trial DetailsNCT01882088
Deglutition Disorders, Digestive System Diseases
Moscow, Russia
View Trial DetailsNCT02873689
Deglutition Disorders, Digestive System Diseases
Beijing, Beijing Municipality, China
View Trial Details